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Dental caries occur as a result of disequilibrium between acid producing pathogenic
bacteria and alkali generating commensal bacteria within a dental biofilm (dental plaque).
Streptococcus mutans has been reported as a primary cariogenic pathogen associated
with dental caries. Emergence of multidrug resistant as well as fluoride resistant strains
of S. mutans due to over use of various antibiotics are a rising problem and prompted the
researchers worldwide to search for alternative therapies. In this perspective, the present
study was aimed to screen selective inhibitors against ComA, a bacteriocin associated
ABC transporter, involved in the quorum sensing of S. mutans. In light of our present
in silico findings, 1,3-disubstituted urea derivatives which had better affinity to ComA
were chemically synthesized in the present study for in vitro evaluation of S. mutans
biofilm inhibition. The results revealed that 1,3-disubstituted urea derivatives showed
good biofilm inhibition. In addition, synthesized compounds exhibited potent synergy with
a very low concentration of fluoride (31.25–62.5 ppm) in inhibiting the biofilm formation
of S. mutans without affecting the bacterial growth. Further, the results were supported
by confocal laser scanning microscopy. On the whole, from our experimental results
we conclude that the combinatorial application of fluoride and disubstituted ureas has
a potential synergistic effect which has a promising approach in combating multidrug
resistant and fluoride resistant S. mutans in dental caries management.
Keywords: Streptococcus mutans, dental caries, fluoride resistant, quorum sensing, synergism, multidrug
resistant
INTRODUCTION
Streptococcus mutans has been reported as a primary cariogenic bacterial pathogen in causing
dental caries, along with other acidogenic bacteria such as Lactobacillus casei, Actinomyces
(Kaur et al., 2015). In addition, this bacterium has also been reported to cause chronic infective
endocarditis which may cause significant morbidity and mortality (Persson, 2012). S. mutans
has established various characteristic mechanisms for its unhindered growth and survival in the
complex microbial community of the oral cavity. Major virulence factors such as acidogenicity,
aciduricity, and the ability to synthesize extracellular polysaccharides from carbohydrates such as
sucrose using enzymes such as glucosyltransferases (GTFs) and collagenanses, reported to have
Kaur et al. Synergistic Studies against S. mutans
ability to bind and degrade collagen type I, a major component
of dentin (Han et al., 2006) are a few among such mechanisms
(Hasan et al., 2012). The glucan synthesis plays a crucial role
in biofilm formation of dentine commonly known as dental
plaque (Lynch et al., 2013). Recent advances in understanding the
communication between bacterial communities have established
that like various other bacteria, S. mutans also regulate the
process of biofilm formation through quorum sensing (QS)
system (Miller and Bassler, 2001). QS circuit in S. mutans consists
of two component signal transduction system (TCSTS) that
specifically detect and respond to the signaling peptide known
as Competence Stimulating Peptide (CSP) (Kleerebezem et al.,
1997). The CSP is synthesized as a propeptide by comC which is
then processed and matured by an ABC transporter ComA with
the help of an accessory protein ComB and finally secreted to
the extracellular environment. The secreted peptide is detected
by the ComD, a histidine kinase protein receptor resulting in
phosphorylation of its cytoplasmic response regulator, ComR
thus, enabling the cell to respond to the peptide via regulation
of gene expression controlling various virulence factors such as
genetic competence and biofilm formation (Kotake et al., 2008).
Biofilm formation is one of the significant characteristics
in various infectious diseases as it provides various advantages
to bacteria such as protection from host defense system,
sequestration of nutrients, utilization of community benefits,
and protection from various antimicrobials since it acts as a
diffusion barrier for those agents to penetrate deep into the
biofilms (Senadheera and Cvitkovitch, 2008). Targeting one of
the crucial components involved in QS circuit can lead to
biofilm inhibition (Qi et al., 2005; Rasmussen and Givskov, 2006;
Ravichandiran et al., 2013). Development of novel drugs against
biofilm formation, a major virulence factor in dental caries aids
in the effective clearance of S. mutans when used in combination
with very low concentrations of antimicrobials thus combating
multidrug resistance (Chen et al., 2016).
Fluoride has been used long as an effective anti-caries agent in
various commercial formulations and is the mainstay for caries
prevention (Zheng et al., 2015). It exerts major effects by reducing
enamel demineralization and enhancing remineralization of early
caries lesions (Randall et al., 2014). However, fluoride does not
provide complete protection in its currently used preparations
and moreover, emergence of fluoride resistant S. mutans has also
doubted the prolonged use of fluoride (Mitsuhata et al., 2014).
Although, fluoride at higher concentrations helps in reduction of
dental plaque and also inhibits the growth of dental pathogens,
prolonged use of high concentrations of fluoride has caused
various side effects such as fluorosis and weakened bones (Cavalli
et al., 2011; Santos et al., 2013). Thus, if an additional agent
could be administered synergistically with fluoride, it may lead to
improved cariostatic and disruptive effects with respect to biofilm
formation without increasing fluoride’s exposure.
In view of this hypothesis, ComA was identified as a key
molecule crucial for the initiation of QS system of Streptococcus,
which belongs to a family of bacteriocin-associated ATP-
binding cassette (ABC) transporters. ABC transporters usually
consists of three domains, i.e., N-terminal domain possessing
the proteolytic peptidase activity, a transmembrane domain
involving six membrane-spanning segments, and a C-terminal
ATP-binding domain positioned toward the cytoplasmic face
of the membrane. Proteolytic activity of peptidase domains of
this family is believed to be involved in cleaving their cognate
propeptides after the consensus Gly-Gly motif. The presence of
a cysteine residue is essential to the sequence for the proteolytic
activity of this family of ABC transporters (Kotake et al.,
2008). Recently, the crystal structure of peptidase (PEP) domain
involved in the QS pathway of Streptococcus was reported by
Ishii et al. (2010) and its proteolytic activity substrate recognition
mechanism was reported by Kotake et al. (2008). The key
involvement of ComA in maturation and secretion of CSP
made it as a favorable target for QS inhibition of S. mutans.
Thus, the aims of the present study were (1) to screen selective
inhibitors against ComA, using computational tools utilizing
small compound library and synthesize the screened ligand along
with its derivatives, (2) to evaluate the synthesized compounds
for biofilm inhibition potential against S. mutans, and (3) to
determine the combinatorial biological activity of the synthesized
compounds at lower concentrations of fluoride.
MATERIALS AND METHODS
Ligand and Protein Preparation
The energy minimized 3D coordinates were generated for
all ligands and ligand file was prepared for docking using
Schrödinger LigPrep software (Xiao et al., 2011). An independent
ligand dataset library Zinc database was used for this study
(Irwin and Shoichet, 2005). Since none of the inhibitors
have been reported for PEP-ComA, thus, comparison studies
were not conducted with known inhibitors. The X-ray crystal
structure of the PEP domain of ComA (PDB ID-3K8U) was
retrieved from PDB database and processed for addition of
polar hydrogen and Kollmann charges using Protein Preparation
Wizard (PrepWizard) in Maestro (Schrödinger Suite) (Bernstein
et al., 1978). The prepared protein was treated to be completely
rigid for all docking procedures to minimize the excessive
computation cost. A grid box encompassing the complete
macromolecule was constructed and used for all docking runs
in this study (Osguthorpe et al., 2012). The hydrogen bonds
were optimized and protein minimization was carried out using
the standard protein preparation protocol. The possible options
available for protein minimization included hydrogen only or all-
atom with a criterion based on the root-mean-square deviation
(RMSD) of the heavy atoms relative to their initial location.
Watermolecules were retained through theH-bond optimization
and minimization stages, as without water molecules, the protein
could collapse, or the H-bond networks required for ligand
binding would be disrupted. Although, prior to docking, all the
water molecules (>5 A) were removed. The resultant protein
structure was used for further docking studies with the prepared
ligands.
Molecular Docking Studies
All docking calculations between macromolecule and ligand
datasets were performed with Glide (Grid based LIgandDocking
with Energetics) program in Schrödinger suite (Friesner et al.,
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2004). All the datasets were executed in three consecutive
steps. Precisely, HTVS mode (High-Throughput Virtual
Screening), SP mode (Standard Precision), followed by XP
mode (eXtraPrecision mode) using the default settings. All the
prepared ligands were docked with the target protein using
the induced fit docking (IFD) protocol (Friesner et al., 2006).
Extensive sampling was conducted by SP mode which defines the
interaction sites of ligand with the protein molecule. Resultant
G-scores were considered as the ranking criteria for the selection
of best docked ligands to the target protein.
De novo Drug Designing and Lead
Optimization
The selected ligands were screened based on their respective glide
scores, interaction pattern at the site of interest in the protein
and the functional group of the compounds. The selected ligands
were further run for clustering using Schrödinger Canvas module
(Hartenfeller and Schneider, 2011). The 3D-Pharmacophore and
binary fingerprinting studies optimized the ligands by ruling out
the ligands with similar structures and their interaction with the
protein. Clustering of ligands was followed by optimization of
lead molecules with Schrödinger QuikProp for toxicity analysis
of the selected ligands (Singh and Konwar, 2012). The parameters
in ADMET and TOPKAT (TOxicityPrediction by Komputer
Assisted Technology) was used for the final validation of the
selected compounds and deemed to be the potential leads.
Synthesis of Aromatic 1,3-Disubstituted
Ureas
The 1,3-disubstituted ureas were synthesized by a simple one pot
reaction of aryl isocyanates with the selective amines (Mustafa
et al., 2014). The synthesis process is shown as a reaction scheme
in Figure 1A. For the synthesis of 1,3-disubstituted ureas, a
solution of substituted aniline (3.18 mmol) was mixed in 1,4-
dioxane (5 mL) and aryl isocyanate (1.60 mmol) was added
drop-wise to the reaction mixture and kept for stirring at room
temperature for 18 h. The progress of the reaction was monitored
by thin layer chromatography. The difference in the Rf values of
the reactants and products in the reaction mixture indicated the
completion of the reaction (Figure 1B). After completion of the
reaction, the reaction mixture was cooled down by addition of
crushed ice which resulted in formation of products as solids. The
solid, thus obtained was filtered and washed several times with
cold distilled water followed by washing with hexane to obtain
the pure product. The structures of the synthesized products were
confirmed by 1H and 13C NMR spectroscopy.
Bacterial Strains and Culture Conditions
S. mutansMTCC 497 was received from Microbial Type Culture
Collection (MTCC), Chandigarh, India and was used as a
standard strain in this study. A wild type strain (WT) NG8
was kindly donated by Prof. L. Jeannine Brady, University of
Florida, USA. Two clinical isolates of S. mutans 4SM (multidrug
resistant) and 5SM (fluoride resistant) were received from JSS
Medical College, Mysore, India. All the strains were cultured in
brain heart infusion broth (BHIB)/agar (HiMedia) at 37◦C under
stationary condition. When needed, medium was supplemented
with 2% sucrose. Sodium fluoride and Chlorhexidine diacetate
were purchased from HiMedia (Mumbai, India.)
Effect of 1, 3-Disubstituted Ureas on
Biofilm Development in Static Biofilm
Model
Ninety six well polystyrene microtiter plates were used for
determining minimum biofilm inhibitory concentration (MBIC)
and minimum biofilm eradication concentration (MBEC) assay
(Kolodkin-Gal et al., 2012; Wang et al., 2015). The assays were
carried out against clinical as well as standard isolates of S.
mutans using two-fold microdilution broth procedure as per the
Clinical and Laboratory Standards Institute (CLSI1) standards
with slight modifications as described below (CLSI Approved
Standard—Tenth Edition). S. mutans strains were grown
overnight in BHIB. The overnight cultures were diluted (1:100)
and the initial optical density of the bacterial cultures were
adjusted to 0.08 (OD600) to achieve 10
8 CFU/ml approximately.
The inoculum was inoculated in fresh medium along with
varying concentrations of synthesized compounds ranging from
0.23 to 15 µM as independent experiments (in triplicates).
Plates were incubated for 24 h at 37◦C without shaking.
After incubation, the wells were washed twice with 200 µL
of phosphate buffered saline (PBS) gently to remove the non-
adherent cells. Adherent cells in the biofilm were fixed by adding
200 µL of 100% methanol prior to staining with 200 µL of
0.2% (w/v) crystal violet (CV) for 20 min. The excess stain
was washed twice with PBS and the plates were air dried. The
bound CV in the air dried plates were eluted with 200 µL of
33% acetic acid. The biofilm was quantitatively determined by
measuring the absorbance at OD595 nm in a microtiter plate
reader (iMark, BIORAD, Japan). The lowest concentration in
which the formation of biofilm is inhibited when compared to
the untreated culture control is defined as MBIC i.e., ≥90% (for
MBIC90 or IC90) or ≥50% (for MBIC50 or IC50).
Similarly, MBEC assay was performed as described elsewhere
(Jennings et al., 2014). Briefly, the biofilm of the respective strains
were allowed to grow in polystyrene 96 well microtiter plates for
18 h. After incubation, the wells were washed twice with PBS to
remove planktonic cells followed by addition of fresh medium
along with varying concentrations of synthesized compounds.
The plates were incubated for 3 hwithout shaking followed by CV
staining of wells as described earlier. The absorbance at OD595
nmwas measured. The lowest concentration in which the biofilm
was eradicated when compared to the untreated culture control is
defined as MBEC i.e.,≥90% (for MBEC90 or EC90) or≥50% (for
MBEC50 or EC50). All the assays were performed in triplicates.
Checkerboard Microdilution Assay for
Synergistic Studies
Combinatorial effects between synthesized compounds and
fluoride as well as chlorhexidine was evaluated by a two
1Clinical and Laboratory Standards Institute (CLSI). CLSI Approved Standard—
Tenth Edition). Methods for Dilution Antimicrobial Susceptibility Tests for
Bacteria That Grow AerobicallyCLSI document M07-A10 ISBN 1-56238-987-4;
ISBN 1-56238-988-2.
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FIGURE 1 | (A) Synthesis scheme of 1,3-disubstituted ureas. (B) A thin layer chromatogram showing completion of the reaction (30% Ethyl acetate:Hexane). Spot 1
represents reactant 1 (2,4,6-Trimethyl aniline), spot 2 represents (4-nitrophenyl isocyanate), and P represents their corresponding product
(1-mesityl-3-(4-nitrophenyl)urea). The difference in the Rf values and color change of reactants to products indicates the completion of reaction.
dimensional microdilution assay using 96 well microtiter
plate (Zheng et al., 2015). The final concentrations of fluoride
ranged from 3.90 to 250 ppm and that of chlorhexidine
ranged from 0.003125 to 0.2%. The concentration of fluoride
was selected where it was not inhibiting bacterial growth
and also was not acting as biofilm inhibiting agent. For
chlorhexidine, 0.2% is the highest concentrations which is
used in commercial formulations. For each combination,
each synthesized compound was placed in horizontal rows
while fluoride and chlorhexidine were placed into the vertical
columns. Data were collected using microtiter plate reader
(iMark, BIORAD, Japan) as turbidometric measurements of
absorbance (OD595) after incubation for 24 h. The synergistic
activity was assessed by the currently prevailing two most
widely used approaches i.e., using fractional inhibitory
concentration index (FICI) and Bliss independence model (1E
model).
Synergy Interpretation Using FICI
To determine the effect of the combinatorial treatment to be
synergistic, indifferent or antagonistic, FICI (a nonparametric
method) was calculated (Subramaniam et al., 2014). The
following formulas were used to calculate the FICI of a
combination.
FICI = FIC of compound A + FIC of compound B
Where,
FIC of compound A = (MIC of compound A in
combination)/(MIC of compound A alone).
FIC of compound B = (MIC of compound B in
combination)/(MIC of compound B alone).
Synergy was defined as an FIC index value of ≤0.5.
Indifference or absence of interaction was defined as FICI value
>0.5 but<4. Antagonism was defined as an FICI of>4.
Synergy Interpretation Using Bliss Independence
Model
The bliss independence model or BI theory (Goldoni and
Johansson, 2007; Sun et al., 2008) is described by the following
equation.
Ii = (IA + IB) − (IA X IB) (1)
Where,
Ii = predicted percentage of inhibition of the theoretical
combination of drug A and B.
IA = experimental percentages of inhibition of drug A.
IB = experimental percentages of inhibition of drug B.
I = 1− E (2)
Where,
E= percentage of growth.
Substituting Equation (2) into (1), a resultant equation is given
as
Ei = EA X EB
Where,
Ei = predicted growth percentage of the theoretical
combination of drug A and B.
EA = observed percentage of growth of drug A.
EB = observed percentage of growth of drug B.
Interaction is described by the difference (1E) between the
predicted and the observed growth percentages at various
concentrations as described by the following equation:
1E = Epredicted − Eobserved.
By the nonparametric approach described by Prichard et al.
EA and EB were obtained directly from the experimental data.
Due to the nature of interaction, testing with microtiter plates,
and a two-fold dilution of either drug results in a 1E for each
drug combination. In each of the three independent experiments,
the observed growth percentages derived from the experimental
data (observed values) were subtracted from the predicted
percentages, and then the average difference of three experiments
was calculated. When the average difference as well as its 95%
confidence interval among the three replicates was positive,
statistically significant synergy was claimed; when the difference
as well as its 95% confidence interval was negative, significant
antagonism was claimed.
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Confocal Laser Scanning Microscopy
Imaging of Biofilms
Confocal imaging was performed on bacterial cells grown in the
form of biofilms on the surface of glass slides. The glass slides
were placed inside sterile 50 ml centrifuge tubes containing BHIB
with or without the compounds at concentrations that showed
maximum biofilm inhibition activity in 96 well microtiter plate
experiments (Auty et al., 2001). S. mutans was inoculated and the
tubes were incubated for 8 h. After the incubation time, slides
were processed for CLSM imaging. Briefly, the slides were washed
twice with 1X PBS to remove planktonic cells followed by staining
of attached biofilm with BacLight LIVE/DEAD stain kit (L-7012;
Molecular Probes) according to the manufacturer’s instructions.
Stained slides were imaged using Carl Zeiss confocal microscope
with 63X oil immersion objective.
Statistical Analysis
Graph pad prism software (version 6.01) was used for statistical
analysis. One way ANOVA and multiple comparisons were
carried out. The minimum level of significance was set at P ≤
0.05. All the assays were conducted in triplicates and the results
were expressed as mean± SD.
RESULTS
Docking Studies, Lead Optimization, and
Toxicity Analysis
In the present study, docking analysis revealed several hits
that favorably occupy the active site of ComA. Each ligand
was further evaluated and the compounds were modified to
generate the next generation of molecules with improved binding
affinity and less toxicity with the active site. For better activity
of ComA inhibitors, ligands should optimally interact with at
least one of the four crucial amino acid residues Q11, C17,
H96, D112. Lipinski’s rule of five predicts a high probability
of success or failure of drug likeness for various selected
molecules. Eighty one drug like ligands were subsequently
guided by Lipinski’s rule of three and five, pharmacokinetics
(ADME) and pharmacodynamics. Rule of five states that the
drug likeness for molecules to comply with three or more
of the following rules: Molecular mass <500 dalton, high
lipophilicity,<5 hydrogen bond donors, and<10 hydrogen bond
acceptors.
Selected compounds were further analyzed using the
QuikProp module in Schrodinger for toxicity analysis
(ADMET). The properties considered for toxicity prediction
were QPlogHERG, QPlogBB (Blood-brain barrier), QPlogKhsa
(Human serum albumin), and human oral absorption. Among
the selected 81 ligands, 7 ligands satisfied the Lipinski’s rule of
three and five, and the parameters considered under ADMET
properties as given in Table 1. Further, ligand number 5 (ComAI,
ComA Inhibitor) was selected based on the ease of synthesis with
the available resources.
The selected ComAI was further used to generate derivatives
with improved binding affinity by substituting various functional
groups namely ComAI1, ComAI2, ComAI3, and ComAI4. All
the derivatives showed better binding affinity to the active site
and improved Glide score as compared to the selected ComAI
and no toxicity pattern was observed for the derivatives of
ComAI as given in Table 2. The ComAI as well as the derived
ligands of ComAI interacts and inhibits ComA protein at Q11
through hydrogen bonding along with various other interactions
in protein cleft as given in Figures 2A,B, 3A–D. Apart from the
selected derivatives, one derivative (ComAI’) with no interaction
to the active site was also synthesized to compare and validate the
computational data with in vitro data. Evidently, computational
studies using docking tools exhibited excellent outcomes which
shows that the selected ligands have potential binding affinity to
ComA.
Synthesis of 1,3-Disubstituted Ureas
The spectral data (1H-NMR and 13C-NMR) of all the
synthesized compounds were in full agreement with the proposed
structures (Table 3). The NMR data is given in Supplementary
Material.
Anti-Biofilm Effects of 1,
3-Disubstitutedureas on S. mutans Biofilm
Development in Static Biofilm Model
Under static conditions, all the compounds except ComAI’ were
found to have antibiofilm effect. Notably, ComAI and ComAI1
showed maximum biofilm inhibition of 50–70% in all the strains
with concentrations ranging from 0.23 to 3.75 µM and 0.93 to
1.87 µM respectively. The results were summarized in Table 4.
In contrast, no biofilm inhibition was found in 5SM strain by
any of the synthesized compounds. In case of eradication assay,
eradication of biofilm was not found by any of the compound.
Considering better biofilm inhibiting activity of ComAI and
ComAI1, they were titled as best amongst all the synthesized
compounds.
Drug Interactions from Synergistic Studies
The results of the checkerboard analysis were interpreted
using the nonparametric methods based on both the Loewe
Additivity (LA) theory and Bliss Independence (BI) theory.
In the checkerboard microtiter plate assay, strong synergism
was concluded in all the isolates of S. mutans analyzed by
both the models i.e., FICI and 1E, and the two models were
found to be in correlation for all the tested compounds in the
study.
FICI
The interpretation of the FICI was based on LA theory according
to which, a FICI value of ≤0.5 revealed synergy, a value of 1–4
revealed indifference, and a value of>4 represented antagonism.
ComAI and its derivatives showed synergistic as well as additive
effects when used in combination with fluoride as shown in
Table 5. In contrast, no synergism was concluded when ComAI
and its derivatives were used along with chlorhexidine. Notably,
when disubstituted ureas as well as fluoride were used alone,
very less or no biofilm inhibition was observed in 5SM strain
but considerable biofilm inhibition was observed when used in
combination. 1,3-disubstituted ureas were found to inhibit the
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TABLE 1 | Final selected ligands after TOPKAT and ADMET properties as ComA inhibitors.
Ligand No. Structure Glide Score Molecular weight Binding site and other characteristic properties
1 −3.915 336.84 Q11, R93, L94
clogP: 2.780
H-Donors: 0
H-Acceptors: 0
Rotatable bonds-7
2 −3.128 335.32 Q11
clogP: 2.510
H-Donors: 2
H-Acceptors: 6
Rotatable bonds: 5
3 −3.433 307.34 H96, Q95, R93
clogP: 2.220
H-Donors: 2
H-Acceptors: 4
Rotatable bonds: 5
4 −3.532 318.25 H96, R93, L94
clogP: 2.580
H-Donors: 1
H-Acceptors: 6
Rotatable bonds: 8
5 −3.088 240.30 Q11
clogP: 3.350
H-Donors: 2
H-Acceptors: 3
Rotatable bonds: 2
6 −4.034 294.33 Q11
clogP: 1.830
H-Donors: 2
H-Acceptors: 5
Rotatable bonds: 3
7 −3.579 322.75 H96, Q95, R93
clogP: 2.860
H-Donors: 1
H-Acceptors: 6
Rotatable bonds: 3
biofilm in combination at a very low concentration of fluoride i.e.,
62.5 ppm. In other strains used in the study, when fluoride was
used alone, it showed antibacterial activity at 500 ppm and higher
concentrations, but there was no antibiofilm activity at any of
the concentrations of fluoride used in the experiment. However,
in synergy experiments with 1,3-disubstituted ureas, fluoride
showed enhanced biofilm inhibitory effect at concentrations
ranging from 31.25 to 62.5 ppm.
Bliss Independence Model (1E Model)
The results for BI model were summarized in Table 6. The 1E
value of each tested concentration was the average of triplicate
results. To summarize the interaction surface, the sums of the
percentages of all statistically significant synergistic (
∑
SYN) and
antagonistic (
∑
ANT) interactions were calculated. Interactions
with <100% statistically significant interactions were considered
as weak, interactions with 100–200% statistically significant
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TABLE 2 | Schematic representation of ADMET and TOPKAT properties of ComAI and its derivatives.
Name Structure Docking score/ Toxicity prediction(ADMET and TOPKAT)
interaction site
Rule of 3 and QPlogHERG QPlogBB QPlogKhsa Human oral
rule of 5 absorption (%)
ComAI −3.088 100
Q11
Derivatives of ComAI
ComAI1 −3.815 100
Q11
ComAI2 −3.334 100
Q11,Q95
ComAI3 −3.214 86.7
Q11, Q47,
L94
ComAI4 −3.342 100
Q11,Q95
ComAI’ −0.485 –
–
Toxicity free behavior.
FIGURE 2 | (A) Binding of ComAI with PEP domain of ComA through Hydrogen bonding (yellow dotted line). (B) Schematic 2D representation of Ligand interaction
pattern of ComAI (ComA Inhibitor) with PEP domain of ComA.
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TABLE 3 | Structures of reactants and their corresponding products.
Ligand name Reactant 1 Reactant 2 Product
ComAI
ComAI1
ComAI2
ComAI3
ComAI4
ComAI1
′
TABLE 4 | IC50 and EC50 values of ComAI and its derivatives.
Compound MTCC497 WT 4SM 5SM
IC(µM) EC(µM) IC(µM) EC(µM) IC(µM) EC(µM) IC(µM) EC(µM)
50 90 50 90 50 90 50 90 50 90 50 90 50 90 50 90
ComAI 3.75 13.5 – – 14.9 – – – 0.39 7.5 – – – 14.8 – –
ComAI1 1.89 12.2 – – – – – – 0.89 – – – – 12.4 – –
ComAI2 – 13 – – 11.5 – – – 1.78 – – – – 15 – –
ComAI3 4.22 14.9 – – – – – – – – – – – 13.8 – –
ComAI4 – – – – 0.46 14 – – 0.41 14.5 – – – 14.5 – –
ComAI1
′
– – – – 14.7 – – – – 13.5 – – – 11.5 – –
IC, inhibitory concentration; EC, Eradication Concentration.
Strains used: MTCC 497, standard reference strain obtained from MTCC, IMTECH, Chandigarh, India; WT, A wild type strain obtained from kindly donated by Prof. L. Jeannine Brady,
University of Florida, USA.; 4SM, Multidrug resistant clinical isolate; 5SM, Fluoride resistant clinical isolate.
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interactions were considered as moderate, and interactions
with >200% statistically significant interactions were considered
as strong, as described previously. In addition, numbers of
statistically significant synergistic and antagonistic combinations
among all tested drug combinations were calculated for each
strain. Bliss independence model was found in coherence with
FIC index and confirmed strong synergism among the1,3-
disubstituted ureas and fluoride whereas, antagonism as well as
indifference was observed in case of chlorhexidine.
Confocal Laser Scanning Microscopy
Imaging of Biofilms
The confocal microscopic images of biofilm stained with
BacLight Live/Dead stain were shown in Figures 4, 5. Absence
of red fluorescence in the merged images from the two filter
sets i.e., for live cells (Syto 9, green) and dead cells (Propidium
iodide, red) showed that the treatments did not affect the survival
of bacteria and the compounds are not antibacterial. This was
further confirmed by plating the planktonic cells and growth
inhibition was not observed (data not shown). Fifty percent
biofilm inhibition was observed in ComAI (1.89 µM) treated
biofilms. Similar results were observed in ComAI1 (3.75 µM)
treated biofilms. No significant biofilm inhibition was observed
in biofilms when treated with fluoride alone whereas in case of
combinatorial treatments, highly significant biofilm inhibition
was observed for both S. mutans strains taken in this study.
DISCUSSION
The exploration for novel therapeutic compounds that act as
antibiofilm and anti-virulent compounds such as 7-fluoroindole,
5-fluorouracil (Attila et al., 2009; Lee et al., 2012) rather than
antibacterial in nature, is one amongst the major research
focus these days to overcome drug resistance. Furthermore,
such anti-virulent compounds when used in combination with
commercially existing protective agents, results in significant
reduction in the over use of these agents. In the present study,
disubstitutedurea compounds were screened and synthesized
and tested for its antibiofilm potential toward S. mutans. In
addition, combinatorial treatment with commercially used anti-
caries agents such as fluoride and chlorhexidine was evaluated in
vitro (Somani et al., 2010; Tong et al., 2011).
In light of our present in silico studies, we have found that
disubstituted ureas have better binding affinity to ComA, a
bacteriocin associated ABC transporter. Moreover, all the derived
compounds have been shown to bind at the active site of PEP
domain of ComA. Blocking of the active site will render the
cleaving property of PEP domain inactivated. Hence, ComA
inhibitors and its derivatives were chemically synthesized and
shown to inhibit the formation of biofilm. Earlier reports by
Mustafa et al. have shown anti-cancerous and enzyme inhibitory
effects of 1,3-disubstituted ureas (Mustafa et al., 2014). Similarly,
fluoride at higher concentrations has been reported to have
antibacterial effects but has not been shown to address biofilm
inhibition, a major virulence trait of the disease effectively
(Zheng et al., 2015). Earlier report by Murata et al. has shown
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FIGURE 3 | Schematic 2D representation of interaction of derivatives of ComAI with PEP domain of ComA. (A) ComAI1; (B) ComAI2; (C) ComAI3; (D)
ComAI4.
TABLE 6 | Delta E model of selected compounds with Fluoride (F) and Chlorhexidine (CHX).
Strains Nonparametric Method
ComAI ComAI1 ComAI2 ComAI3 ComAI4 ComAI1
′
F CHX F CHX F CHX F CHX F CHX F CHX
MTCC 497 1E 1426 −393 1736 −114 1771 −531 1218 −307 – – – –
I SS SA SS MA SS SA SS SA – –
WT 1E 1467 44 – – 1222 22 – – 1584 84 1730 30
I SS WS – – SS WS – – SS WS SS WS
4SM 1E 98 −329 55 −521 78 −283 – – 87 −489 1861 −462
I WS SA WS SA WS SA – – WS SA SS SA
5SM 1E 1548 −378 1120 −241 1004 −283 1217 −228 1725 −532 1939 625
I SS SA SS SA SS SA SS SA SS SA SS SA
SS, Strong Synergism; SA, Strong Antagonism; WS, Weak Synergism; MA, Moderate Antagonism.
that fluoride at a concentration of 125 ppm act synergistically
along with 7-epiclusianone (a naturally occurring compound) to
enhance the cariostatic effect of fluoride (Murata et al., 2010).
Similarly, biofilm inhibition using calcium fluoride nanoparticles
was observed by Kulshrestha et al. (2016).
In the present study, we have reported the effective application
of chemically synthesized 1,3-disubstituted ureas that act as
antibiofilm agents against standard and clinical isolates but
do not have any antibacterial property which is a desirable
characteristic as far as multi-drug resistance is concerned. This
can be attributed to the fact that, since, these compounds
were designed to selectively block the ComA, and thus, the
process of cell to cell communication is inhibited leading
to expression of virulence factor such as biofilm formation.
Moreover, 1,3-disubstituted ureas, when used in combination
with fluoride, significantly reduced the concentration of fluoride
required for prevention of dental caries (1000 ppm used in
the present formulations). In our present study, we have
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FIGURE 4 | Effect of ComAI treatments alone as well as in synergy on
S. mutansMTCC 497 biofilms. Live/Dead staining of bacterial biofilm
observed under confocal laser scanning microscopy (green color-Syto 9). (A)
Control biofilm, (B) ComAI treated biofilm (3.75 µM), (C) Fluoride treated
biofilm (500 ppm), (D) Synergistic activity of ComAI and fluoride (31.25 ppm
fluoride and 3.75 µM ComAI).
reported the concentration of 31.25 ppm which is found to act
synergistically along with ComAI and its derivatives in all the
clinical as well as standard isolates which is relatively very less
fluoride concentration when compared to the presently used
formulations. This suggests that the combinatorial treatment was
effective and ensures the usage of antimicrobial products within
the limits that may reduce or eliminate the chance of resistance
development. However, similar results were not observed with
chlorhexidine.
Enhancement of cario-preventive effects of fluoride by
integrating the natural or synthesized compounds in oral
preparations affecting the virulence of cariogenic bacteria
will lead to the better dental care. Fluoride along with 1,3-
disubstituted ureas clearly has potential to reduce the incidence
of dental caries at a very low concentrations thus, avoiding the
harmful effects of increased exposure of fluoride to individuals.
FIGURE 5 | Effect of ComAI treatments alone as well as in synergy on
S. mutans 5SM (clinical isolate) biofilms. Live/Dead staining of bacterial
biofilm observed under confocal laser scanning microscopy (green color-Syto
9). (A) Control biofilm, (B) ComAI treated biofilm (15 µM), (C) Fluoride treated
biofilm (500 ppm), (D) Synergistic activity of ComAI and fluoride (31.25 ppm
fluoride and 15 µM ComAI).
Collectively, based on the in vitro studies, our data shows that
1,3-disubstituted ureas reduces biofilm formation when used
alone or in combination with fluoride without reducing its
cariostatic properties. The combination of fluoride with 1,3-
disubstituted ureas may provide a potentially useful alternative
to the current chemo-based anti-caries strategies to prevent
dental caries disease. However, additional studies are essential
to elucidate the molecular mechanisms of action of these agents
and optimize the combinations. This would enhance the present
effectiveness of anti-caries chemotherapy.
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